ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,353Medicare Part D Prescriptions Filled, Including Refills

Rank: 89 out of 5176

$2.26M Total Retail Price of All Prescriptions

Rank: 35 out of 5176

329 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
100% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 329 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

4% of this provider’s 329 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

0% of this provider’s 19,148 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

56% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$111 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

62 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
METOPROLOL SUCCINATE 1,042 987 1 11
NEXIUM 754 720 2 16
PLAVIX 686 664 3 29
CRESTOR 671 644 4 15
CLOPIDOGREL 420 402 5 26
CLONIDINE HCL 403 385 6 79
ZETIA 358 350 7 68
ZOLPIDEM TARTRATE 345 326 8 17
ATORVASTATIN CALCIUM 344 334 9 9
ALENDRONATE SODIUM 317 302 10 18
OMEPRAZOLE 309 278 11 3
CLONIDINE 301 287 10 12 295
SPIRONOLACTONE 301 298 12 88
COLCRYS 293 245 10 14 170
LANTUS SOLOSTAR 282 278 15 70
VICTOZA 3-PAK 274 242 10 16 322
SIMVASTATIN 273 250 17 1
LOSARTAN-HYDROCHLOROTHIAZIDE 268 262 18 35
ALLOPURINOL 264 235 19 41
CELEBREX 257 251 20 80
AMLODIPINE BESYLATE 251 249 21 2
NIFEDIPINE ER 241 241 22 48
METOPROLOL TARTRATE 238 223 23 6
FUROSEMIDE 236 214 24 8
LIPITOR 230 218 25 51
ULORIC 217 194 26 280
JANUVIA 217 217 26 25
GABAPENTIN 217 186 26 21
BUMETANIDE 216 216 29 209
BYETTA 193 187 30 361
RANITIDINE HCL 188 175 31 36
ADVAIR DISKUS 179 165 32 32
DEXILANT 171 170 33 118
SYNTHROID 170 170 34 33
NAMENDA 167 165 35 47
DIOVAN HCT 154 142 36 39
PEN NEEDLE 146 137 37 144
LOVAZA 142 138 38 43
BENICAR HCT 140 125 39 110
TAMSULOSIN HCL 126 126 40 20
FINASTERIDE 126 126 40 69
LOVASTATIN 125 122 42 46
LIDODERM 121 120 43 59
ONGLYZA 121 107 43 153
CARVEDILOL 117 113 45 24
NIASPAN 116 116 46 175
ATENOLOL 110 98 47 12
LANSOPRAZOLE 110 104 47 113
BONIVA 108 102 49 236
TOPROL XL 107 93 50 227
SPIRIVA 106 97 51 54
VYTORIN 105 91 52 152
ALCOHOL SWABS 105 94 52 115
CREON 105 105 52 111
DOXAZOSIN MESYLATE 103 91 55 103
SINGULAIR 98 97 56 62
RAMIPRIL 95 95 57 50
TRICOR 94 82 58 148
HYDROCHLOROTHIAZIDE 93 93 59 10
DIOVAN 93 93 59 19
JANUMET 92 78 61 77
TORSEMIDE 88 80 62 184
LANTUS 86 76 63 66
BYDUREON 84 77 64 477
BENICAR 82 80 65 100
DONEPEZIL HCL 81 81 66 28
ENALAPRIL MALEATE 81 81 66 22
AMITIZA 78 78 68 197
AVODART 77 77 69 107
AMLODIPINE BESYLATE-BENAZEPRIL 77 77 69 55
LOSARTAN POTASSIUM 75 73 71 14
ISOSORBIDE MONONITRATE ER 73 59 72 44
AZITHROMYCIN 71 66 73 42
QUINAPRIL HCL 69 69 74 82
GLIMEPIRIDE 67 67 75 37
PRADAXA 66 66 76 192
PROAIR HFA 66 56 76 60
MELOXICAM 65 57 78 53
CHLORHEXIDINE GLUCONATE 63 63 79 202
BYSTOLIC 62 62 80 96
PANTOPRAZOLE SODIUM 62 62 80 61
CLOTRIMAZOLE-BETAMETHASONE 61 56 82 94
METFORMIN HCL 61 61 82 7
RANEXA 60 60 84 167
ZOVIRAX 59 59 85 313
UNIFINE PENTIPS 59 59 85 261
TEKTURNA 59 59 85 255
KOMBIGLYZE XR 59 58 85 291
LACTULOSE 55 39 89 87
WELCHOL 53 39 90 230
COUMADIN 50 50 91 112
ESCITALOPRAM OXALATE 50 48 91 89
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 15, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.